HEADER TRANSPORT PROTEIN 03-SEP-20 7CYG TITLE CRYSTAL STRUCTURE OF A CYSTEINE-PAIR MUTANT (Y113C-P190C) OF A TITLE 2 BACTERIAL BILE ACID TRANSPORTER BEFORE DISULFIDE BOND FORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSPORTER, SODIUM/BILE ACID SYMPORTER FAMILY; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: YERSINIA FREDERIKSENII; SOURCE 3 ORGANISM_TAXID: 29484; SOURCE 4 GENE: NCTC11470_02445; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BILE ACID TRANSPORTER, ASBT, NTCP, SLC10, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.WANG,Y.LYU,Y.JI,Z.SUN,X.ZHOU REVDAT 2 29-NOV-23 7CYG 1 REMARK REVDAT 1 13-JAN-21 7CYG 0 JRNL AUTH X.WANG,Y.LYU,Y.JI,Z.SUN,X.ZHOU JRNL TITL AN ENGINEERED DISULFIDE BRIDGE TRAPS AND VALIDATES AN JRNL TITL 2 OUTWARD-FACING CONFORMATION IN A BILE ACID TRANSPORTER. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 77 108 2021 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 33404530 JRNL DOI 10.1107/S205979832001517X REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.6 REMARK 3 NUMBER OF REFLECTIONS : 9556 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.265 REMARK 3 R VALUE (WORKING SET) : 0.263 REMARK 3 FREE R VALUE : 0.301 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 474 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.6840 - 4.6107 1.00 3360 180 0.2596 0.2986 REMARK 3 2 4.6107 - 3.6609 0.89 2840 162 0.2617 0.2919 REMARK 3 3 3.6609 - 3.1984 0.88 2882 132 0.2702 0.3286 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.480 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.92 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND RESID 4 THROUGH 302) REMARK 3 SELECTION : CHAIN B REMARK 3 ATOM PAIRS NUMBER : 2718 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7CYG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1300018446. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JAN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9785 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.3 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9572 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.198 REMARK 200 RESOLUTION RANGE LOW (A) : 45.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.10700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.37200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4N7W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M NA+-PHOSPHATE/CITRATE PH 4.7, REMARK 280 36% PEG 300, LIPIDIC CUBIC PHASE, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 94.80250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.58200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 94.80250 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.58200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 465 LEU B 2 REMARK 465 VAL B 3 REMARK 465 LYS B 303 REMARK 465 LYS B 304 REMARK 465 ASP B 305 REMARK 465 GLN B 306 REMARK 465 GLU B 307 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 271 -75.23 -134.58 REMARK 500 PHE B 271 -76.25 -134.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6LH1 RELATED DB: PDB REMARK 900 6LH1 CONTAINS THE SAME MUTATIONS OF THE SAME PROTEIN WITH DISULFIDE REMARK 900 BOND FORMED. DBREF1 7CYG A 1 307 UNP A0A380PV03_YERFR DBREF2 7CYG A A0A380PV03 1 307 DBREF1 7CYG B 1 307 UNP A0A380PV03_YERFR DBREF2 7CYG B A0A380PV03 1 307 SEQADV 7CYG CYS A 113 UNP A0A380PV0 TYR 113 ENGINEERED MUTATION SEQADV 7CYG CYS A 190 UNP A0A380PV0 PRO 190 ENGINEERED MUTATION SEQADV 7CYG CYS B 113 UNP A0A380PV0 TYR 113 ENGINEERED MUTATION SEQADV 7CYG CYS B 190 UNP A0A380PV0 PRO 190 ENGINEERED MUTATION SEQRES 1 A 307 MET LEU VAL LYS ILE THR ARG LEU PHE PRO VAL TRP ALA SEQRES 2 A 307 LEU LEU LEU SER VAL ALA ALA TYR PHE ARG PRO THR THR SEQRES 3 A 307 PHE THR GLY ILE GLY PRO TYR VAL GLY PRO LEU LEU MET SEQRES 4 A 307 LEU ILE MET PHE ALA MET GLY VAL THR LEU ARG LEU ASP SEQRES 5 A 307 ASP PHE LYS ARG VAL LEU SER ARG PRO ALA PRO VAL ALA SEQRES 6 A 307 ALA ALA THR PHE LEU HIS TYR LEU ILE MET PRO LEU THR SEQRES 7 A 307 ALA TRP ILE LEU ALA MET LEU PHE ARG MET PRO PRO ASP SEQRES 8 A 307 LEU SER ALA GLY MET VAL LEU VAL GLY SER VAL ALA SER SEQRES 9 A 307 GLY THR ALA SER ASN VAL MET ILE CYS LEU ALA LYS GLY SEQRES 10 A 307 ASP VAL ALA LEU SER VAL THR ILE SER ALA VAL SER THR SEQRES 11 A 307 LEU VAL GLY VAL PHE ALA THR PRO LEU LEU THR ARG LEU SEQRES 12 A 307 TYR VAL ASP ALA THR ILE SER VAL ASP VAL VAL GLY MET SEQRES 13 A 307 LEU LYS SER ILE LEU GLN ILE VAL VAL ILE PRO ILE THR SEQRES 14 A 307 ALA GLY LEU VAL ILE HIS HIS THR PHE THR LYS THR VAL SEQRES 15 A 307 LYS ARG ILE GLU PRO TYR LEU CYS ALA MET SER MET VAL SEQRES 16 A 307 CYS ILE LEU ALA ILE ILE SER ALA VAL VAL ALA GLY SER SEQRES 17 A 307 GLN SER HIS ILE ALA SER VAL GLY PHE VAL VAL ILE ILE SEQRES 18 A 307 ALA VAL ILE LEU HIS ASN GLY ILE GLY LEU LEU SER GLY SEQRES 19 A 307 TYR TRP GLY GLY LYS LEU PHE GLY PHE ASP GLU SER THR SEQRES 20 A 307 CYS ARG THR LEU ALA ILE GLU VAL GLY MET GLN ASN SER SEQRES 21 A 307 GLY LEU ALA ALA THR LEU GLY LYS ILE TYR PHE SER PRO SEQRES 22 A 307 LEU ALA ALA LEU PRO GLY ALA LEU PHE SER VAL TRP HIS SEQRES 23 A 307 ASN LEU SER GLY SER LEU LEU ALA GLY TYR TRP SER GLY SEQRES 24 A 307 LYS PRO VAL LYS LYS ASP GLN GLU SEQRES 1 B 307 MET LEU VAL LYS ILE THR ARG LEU PHE PRO VAL TRP ALA SEQRES 2 B 307 LEU LEU LEU SER VAL ALA ALA TYR PHE ARG PRO THR THR SEQRES 3 B 307 PHE THR GLY ILE GLY PRO TYR VAL GLY PRO LEU LEU MET SEQRES 4 B 307 LEU ILE MET PHE ALA MET GLY VAL THR LEU ARG LEU ASP SEQRES 5 B 307 ASP PHE LYS ARG VAL LEU SER ARG PRO ALA PRO VAL ALA SEQRES 6 B 307 ALA ALA THR PHE LEU HIS TYR LEU ILE MET PRO LEU THR SEQRES 7 B 307 ALA TRP ILE LEU ALA MET LEU PHE ARG MET PRO PRO ASP SEQRES 8 B 307 LEU SER ALA GLY MET VAL LEU VAL GLY SER VAL ALA SER SEQRES 9 B 307 GLY THR ALA SER ASN VAL MET ILE CYS LEU ALA LYS GLY SEQRES 10 B 307 ASP VAL ALA LEU SER VAL THR ILE SER ALA VAL SER THR SEQRES 11 B 307 LEU VAL GLY VAL PHE ALA THR PRO LEU LEU THR ARG LEU SEQRES 12 B 307 TYR VAL ASP ALA THR ILE SER VAL ASP VAL VAL GLY MET SEQRES 13 B 307 LEU LYS SER ILE LEU GLN ILE VAL VAL ILE PRO ILE THR SEQRES 14 B 307 ALA GLY LEU VAL ILE HIS HIS THR PHE THR LYS THR VAL SEQRES 15 B 307 LYS ARG ILE GLU PRO TYR LEU CYS ALA MET SER MET VAL SEQRES 16 B 307 CYS ILE LEU ALA ILE ILE SER ALA VAL VAL ALA GLY SER SEQRES 17 B 307 GLN SER HIS ILE ALA SER VAL GLY PHE VAL VAL ILE ILE SEQRES 18 B 307 ALA VAL ILE LEU HIS ASN GLY ILE GLY LEU LEU SER GLY SEQRES 19 B 307 TYR TRP GLY GLY LYS LEU PHE GLY PHE ASP GLU SER THR SEQRES 20 B 307 CYS ARG THR LEU ALA ILE GLU VAL GLY MET GLN ASN SER SEQRES 21 B 307 GLY LEU ALA ALA THR LEU GLY LYS ILE TYR PHE SER PRO SEQRES 22 B 307 LEU ALA ALA LEU PRO GLY ALA LEU PHE SER VAL TRP HIS SEQRES 23 B 307 ASN LEU SER GLY SER LEU LEU ALA GLY TYR TRP SER GLY SEQRES 24 B 307 LYS PRO VAL LYS LYS ASP GLN GLU HELIX 1 AA1 LEU A 2 ARG A 23 1 22 HELIX 2 AA2 ARG A 23 THR A 28 1 6 HELIX 3 AA3 GLY A 29 PRO A 32 5 4 HELIX 4 AA4 TYR A 33 VAL A 47 1 15 HELIX 5 AA5 THR A 48 LEU A 49 5 2 HELIX 6 AA6 ARG A 50 SER A 59 5 10 HELIX 7 AA7 ARG A 60 PHE A 86 1 27 HELIX 8 AA8 PRO A 89 VAL A 102 1 14 HELIX 9 AA9 SER A 108 ALA A 115 1 8 HELIX 10 AB1 ASP A 118 VAL A 145 1 28 HELIX 11 AB2 ASP A 152 VAL A 164 1 13 HELIX 12 AB3 VAL A 164 PHE A 178 1 15 HELIX 13 AB4 PHE A 178 SER A 208 1 31 HELIX 14 AB5 SER A 208 PHE A 241 1 34 HELIX 15 AB6 ASP A 244 MET A 257 1 14 HELIX 16 AB7 ASN A 259 PHE A 271 1 13 HELIX 17 AB8 PRO A 273 ALA A 275 5 3 HELIX 18 AB9 ALA A 276 SER A 298 1 23 HELIX 19 AC1 ILE B 5 ARG B 23 1 19 HELIX 20 AC2 ARG B 23 THR B 28 1 6 HELIX 21 AC3 GLY B 29 PRO B 32 5 4 HELIX 22 AC4 TYR B 33 VAL B 47 1 15 HELIX 23 AC5 THR B 48 ARG B 50 5 3 HELIX 24 AC6 LEU B 51 ARG B 60 1 10 HELIX 25 AC7 ARG B 60 PHE B 86 1 27 HELIX 26 AC8 PRO B 89 VAL B 102 1 14 HELIX 27 AC9 SER B 108 ALA B 115 1 8 HELIX 28 AD1 ASP B 118 VAL B 145 1 28 HELIX 29 AD2 ASP B 152 VAL B 164 1 13 HELIX 30 AD3 VAL B 164 PHE B 178 1 15 HELIX 31 AD4 PHE B 178 SER B 208 1 31 HELIX 32 AD5 SER B 208 PHE B 241 1 34 HELIX 33 AD6 ASP B 244 MET B 257 1 14 HELIX 34 AD7 ASN B 259 PHE B 271 1 13 HELIX 35 AD8 PRO B 273 ALA B 275 5 3 HELIX 36 AD9 ALA B 276 SER B 298 1 23 CRYST1 189.605 47.164 70.681 90.00 100.84 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005274 0.000000 0.001010 0.00000 SCALE2 0.000000 0.021203 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014405 0.00000